Latest News about Patient Enrollment
Recent news which mentions Patient Enrollment
Axsome Therapeutics Commences Late-Stage Migraine Study
September 01, 2022
Tickers
AXSM
From Benzinga
Cue Biopharma Shares Decline Following Initial-Stage Metastatic Cancer Study Kicks-off
August 22, 2022
Tickers
CUE
From Benzinga
Avalo Therapeutics' Shares Climb Following Patient Dosing in Immunodeficiency Disorder Study
August 02, 2022
Tickers
AVTX
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.